Englander Institute for Precision Medicine

Two distinct immunopathological profiles in autopsy lungs of COVID-19.

TitleTwo distinct immunopathological profiles in autopsy lungs of COVID-19.
Publication TypeJournal Article
Year of Publication2020
AuthorsNienhold R, Ciani Y, Koelzer VH, Tzankov A, Haslbauer JD, Menter T, Schwab N, Henkel M, Frank A, Zsikla V, Willi N, Kempf W, Hoyler T, Barbareschi M, Moch H, Tolnay M, Cathomas G, Demichelis F, Junt T, Mertz KD
JournalNat Commun
Volume11
Issue1
Pagination5086
Date Published2020 Oct 08
ISSN2041-1723
KeywordsAged, Aged, 80 and over, Betacoronavirus, CD8-Positive T-Lymphocytes, Coronavirus Infections, COVID-19, Cytokines, Female, Gene Expression Profiling, Humans, Interferons, Lung, Macrophages, Male, Middle Aged, Pandemics, Pneumonia, Viral, SARS-CoV-2, Viral Load
Abstract

Coronavirus Disease 19 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has grown to a worldwide pandemic with substantial mortality. Immune mediated damage has been proposed as a pathogenic factor, but immune responses in lungs of COVID-19 patients remain poorly characterized. Here we show transcriptomic, histologic and cellular profiles of post mortem COVID-19 (n = 34 tissues from 16 patients) and normal lung tissues (n = 9 tissues from 6 patients). Two distinct immunopathological reaction patterns of lethal COVID-19 are identified. One pattern shows high local expression of interferon stimulated genes (ISG) and cytokines, high viral loads and limited pulmonary damage, the other pattern shows severely damaged lungs, low ISGs (ISG), low viral loads and abundant infiltrating activated CD8 T cells and macrophages. ISG patients die significantly earlier after hospitalization than ISG patients. Our study may point to distinct stages of progression of COVID-19 lung disease and highlights the need for peripheral blood biomarkers that inform about patient lung status and guide treatment.

DOI10.1038/s41467-020-18854-2
Alternate JournalNat Commun
PubMed ID33033248
PubMed Central IDPMC7546638

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021